Flaxseed sprouts induce apoptosis and inhibit growth in MCF-7 and MDA-MB-231 human breast cancer cells



Flaxseeds have been shown to play a role in the prevention of cancer and heart disease, and it is believed that their more favorable fatty acid composition is responsible. Sprouting is a natural method to modify nutritional components and to decrease cyanide poisoning of raw flaxseeds. Here, we investigated the in vitro effects of flaxseed sprouts on cell growth and apoptosis of human breast cancer cells. In a series of in vitro experiments, estrogen-receptor-positive (MCF-7) and estrogen-receptor-negative (MDA-MB-231) cells were cultured and treated with flaxseed sprouts, and then cell proliferation, apoptosis, and gene expression were measured. Flaxseed sprouts significantly reduced the growth of both of MCF-7 and MDA-MB-231 cells and also increased apoptosis. However, flaxseed sprouts did not affect the growth of MCF-10A mammary epithelial cells. In gene transcription analysis using quantitative real-time polymerase chain reaction, flaxseed sprout treatment significantly upregulated p53 mRNA in both cell cancer lines. These results suggest that flaxseed sprouts induce apoptosis and inhibit cancer cell growth, thereby demonstrating their anti-proliferative effects in breast cancer cells. This study may provide important information for devising dietary strategies to reduce breast cancer risk.


Flaxseed sprouts Breast cancer Apoptosis p53 


  1. Bergman Jungeström M.; Thompson L. U.; Dabrosin C. Flaxseed and its lignans inhibit estradiol-induced growth, angiogenesis, and secretion of vascular endothelial growth factor in human breast cancer xenografts in vivo. Clin. Cancer Res. 13: 1061–1067; 2007.PubMedCrossRefGoogle Scholar
  2. Call J. A.; Eckhardt S. G.; Camidge D. R. Targeted manipulation of apoptosis in cancer treatment. Lancet Oncol. 9: 1002–1011; 2008.PubMedCrossRefGoogle Scholar
  3. Chadha R. K.; Lawrence J. F.; Ratnayake W. M. Ion chromatographic determination of cyanide released from flaxseed under autohydrolysis conditions. Food Addit. Contam. 12: 527–533; 1995.PubMedCrossRefGoogle Scholar
  4. Chajès V.; Sattler W.; Stranzl A.; Kostner G. M. Influence of n-3 fatty acids on the growth of human breast cancer cells in vitro: relationship to peroxides and vitamin-E. Breast Cancer Res. Treat. 34: 199–212; 1995.PubMedCrossRefGoogle Scholar
  5. Chen J.; Saggar J. K.; Corey P.; Thompson L. U. Flaxseed and pure secoisolariciresinol diglucoside, but not flaxseed hull, reduce human breast tumor growth (MCF-7) in athymic mice. J. Nutr. 139: 2061–2066; 2009.PubMedCrossRefGoogle Scholar
  6. Cho K.; Mabasa L.; Fowler A. W.; Walsh D. M.; Park C. S. Canola oil inhibits breast cancer cell growth in cultures and in vivo and acts synergistically with chemotherapeutic drugs. Lipids 45: 777–784; 2010.PubMedCrossRefGoogle Scholar
  7. Eischen C. M.; Lozano G. p53 and MDM2: antagonists or partners in crime? Cancer Cell. 15: 161–162; 2009.PubMedCrossRefGoogle Scholar
  8. Garcia-Gonzalez L.; Geeraerd A. H.; Spilimbergo S.; Elst K.; Van Ginneken L.; Debevere J.; Van Impe J. F.; Devlieghere F. High pressure carbon dioxide inactivation of microorganisms in foods: the past, the present and the future. Int. J. Food Microbiol. 117: 1–28; 2007.PubMedCrossRefGoogle Scholar
  9. Haupt Y.; Maya R.; Kazaz A.; Oren M. Mdm2 promotes the rapid degradation of p53. Nature 387: 296–299; 1997.PubMedCrossRefGoogle Scholar
  10. Kelley D. S. Modulation of human immune and inflammatory responses by dietary fatty acids. Nutrition 17: 669–673; 2001.PubMedCrossRefGoogle Scholar
  11. Kubbutat M. H. G.; Jones S. N.; Vousden K. H. Regulation of p53 stability by Mdm2. Nature 387: 299–303; 1997.PubMedCrossRefGoogle Scholar
  12. Kussie P. H.; Gorina S.; Marechal V.; Elenbaas B.; Moreau J.; Levine A. J.; Pavletich N. P. Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science 274: 948–953; 1996.PubMedCrossRefGoogle Scholar
  13. Lewis J. S.; Jordan V. C. Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance. Mutat. Res. 591: 247–263; 2005.PubMedCrossRefGoogle Scholar
  14. Paruthiyil S.; Parmar H.; Kerekatte V.; Cunha G. R.; Firestone G. L.; Leitman D. C. Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest. Cancer Res. 64: 423–428; 2004.PubMedCrossRefGoogle Scholar
  15. Ridel S. J.; Shi Y. Molecular mechanisms of caspase regulation during apoptosis. Nat. Rev. Mol. Cell Biol. 5: 897–907; 2004.CrossRefGoogle Scholar
  16. Rose D. P.; Connolly J. M. Omega-3 fatty acids as cancer chemopreventive agents. Pharmacol. Ther. 83: 217–244; 1999.PubMedCrossRefGoogle Scholar
  17. Shahidi F.; Wanasundara P. K. Cyanogenic glycosides of flaxseeds. ACS Symp. Ser. 662: 171–185; 1997.CrossRefGoogle Scholar
  18. Tou J. C.; Chen J.; Thompson L. U. Flaxseed and its lignan precursor, secoisolariciresinol diglycoside, affect pregnancy outcome and reproductive development in rats. J. Nutr. 128: 1861–1868; 1998.PubMedGoogle Scholar
  19. Wanasundra P. K.; Shahidi F.; Brosnan M. E. Changes in flax (Linum usitatissimum) seed nitrogenous compounds during germination. Food Chem 65: 289–295; 1999.CrossRefGoogle Scholar
  20. Yang H.; Sun W.; Zhong Y. Four detoxification technologies of flaxseed. Shipin Kexue 29: 245–248; 2008.Google Scholar

Copyright information

© The Society for In Vitro Biology 2012

Authors and Affiliations

  1. 1.Department of Chemistry and BiochemistryNorth Dakota State UniversityFargoUSA
  2. 2.Department of Animal SciencesNorth Dakota State UniversityFargoUSA

Personalised recommendations